Current models suggest that DLK1 is an inhibitory ligand in the Notch pathway. Here, the authors show that DLK1 does not interact with Notch receptors, instead blocking Activin signaling via an interaction with Activin receptor type-2B.
- Daniel Antfolk
- Qianqian Ming
- Vincent C. Luca